|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 02/08/12 | Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading | RE |
| 16/07/12 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.61% | +2.88% | +27.07% | +30.47% | +7.99% | +45.63% | +0.39% | +24.56% | +108.26% | 82.73B | |
| -0.10% | +4.26% | +49.14% | +79.13% | +0.54% | -19.33% | -35.22% | -43.66% | +59.17% | 57.94B | |
| +14.36% | +152.27% | +193.75% | +238.80% | +438.59% | +526.55% | +41.90% | -60.08% | - | 55.45B | |
| +0.76% | +3.53% | +4.41% | +12.01% | -6.49% | +0.08% | +36.18% | +7.05% | - | 52.57B | |
| +1.86% | +3.13% | -8.90% | -8.38% | -6.08% | +11.49% | +174.36% | +128.81% | +211.12% | 48.94B | |
| +1.21% | +3.87% | +9.19% | +13.94% | +25.44% | +61.90% | -16.51% | -35.59% | -28.05% | 32.23B | |
| +1.36% | +5.06% | +10.24% | +33.51% | +31.34% | +53.04% | +103.13% | +71.22% | +61.95% | 25.94B | |
| +8.39% | +10.64% | +21.66% | +36.13% | +42.56% | +13.52% | +212.81% | +75.61% | - | 22.1B | |
| +3.89% | +1.08% | +2.67% | +5.01% | +41.11% | +61.82% | +112.10% | +168.80% | +371.01% | 16.55B | |
| -4.68% | +2.52% | +32.16% | +8.96% | -11.65% | -9.33% | +752.25% | +465.34% | +6,757.27% | 16.13B | |
| -0.83% | -3.11% | -4.31% | +16.32% | +5.11% | +70.01% | +170.89% | +59.78% | - | 15.85B | |
| +1.61% | -1.30% | +11.44% | +22.24% | +11.26% | +13.03% | -29.39% | -15.79% | -30.38% | 12.6B | |
| +0.04% | -4.73% | -14.74% | -12.92% | +12.51% | +76.67% | +168.04% | +711.21% | +2,661.83% | 10.76B | |
| +4.23% | +7.02% | +6.27% | +18.95% | +44.48% | +142.69% | +182.47% | +524.68% | - | 10.11B | |
| +7.54% | +30.42% | +67.74% | +149.99% | +377.36% | +452.83% | +665.52% | +34.78% | - | 8.83B | |
| +1.67% | +2.96% | +4.03% | +3.60% | -6.12% | -17.93% | -21.65% | -51.38% | -47.52% | 6.94B | |
| +1.03% | +0.89% | +27.63% | +50.64% | +94.42% | +142.74% | +359.60% | +522.19% | - | 6.19B | |
| +5.06% | -5.24% | +8.66% | +28.44% | +1.04% | -3.87% | +62.41% | -16.80% | - | 5.8B | |
| +0.02% | -10.10% | +1.78% | +3.56% | +5.79% | +16.91% | +231.67% | +222.01% | - | 5.79B | |
| Average | +2.54% | +11.58% | +23.68% | +38.44% | +58.38% | +86.23% | +166.89% | +146.99% | +1,012.47% | 24.67B | |
| Weighted average by Cap. | +2.82% | +22.33% | +36.61% | +51.38% | +65.17% | +91.88% | +95.72% | +68.09% | +535.72% |
- Stock Market
- Stocks
- Stock
- Sector Amylin Pharmaceuticals LLC
Select your edition
All financial news and data tailored to specific country editions
